Skip to main content

Table 1 Background of respondents

From: A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors

 

n = 301

Q1. Which Medical institution do you belong to?

 Hospital

289 (96.0)a

 Clinic

2 (0.7)

 Pharmacy

6 (2.0)

 Others

4 (1.3)

Q2. Do you have any certified in society (multiple choice)?

 JOP

69 (22.9)

 JSOP

39 (13.0)

 POP

133 (44.2)

 APACC

43 (14.3)

 BCPPP

78 (25.9)

 None

53 (17.6)

Q3. How many duty career of clinical (year) do you have?

5

13 (4.3)

 5–10

78 (25.9)

 11–20

156 (51.8)

 21–30

45 (15.0)

31

9 (3.0)

Q4. Was your medical institution designated Regional Cancer Centers and Hospitals?

 Yes

185 (61.5)

 No

116 (38.5)

Q5. How many hospital beds does your medical institution have?

 None

7 (2.3)

 < 20

2 (0.7)

 20–200

27 (9.0)

 201–500

122 (40.5)

 501–1000

124 (41.2)

1001

19 (6.3)

  1. JOP JSPHCS-certified Oncology Pharmacist, JSOP JSPHCS-certified Senior Oncology Pharmacist, POP Board Certified Pharmacist in Oncology Pharmacy, APACC Accredited Pharmacist of Ambulatory Cancer Chemotherapy, BCPPP Board Certified Pharmacist in Palliative Pharmacy
  2. aNumber (percent)